Newsroom

Modell Antikörper
News
An international research team of the Technische Universität Braunschweig and the Helmholtz Centre for Infection Research (HZI), led by the Department of Biotechnology of the TU Braunschweig, has reported on the development of special antibodies against SARS-CoV-2 in the journal Nature Communications. These antibodies prevent the viruses from entering host cells and were isolated from an antibody gene library that had already been produced from immune cells of healthy donors before the pandemic. The study shows how, in the future, active substances to previously unknown, emerging viruses can be produced very quickly without patient material.
11.03.2021
News
The CoVerage tool analyses the lineage dynamics of SARS-CoV-2 strains, i.e. determines how successfully which virus strain spreads. The web resource uses input from the Gisaid genome database. Gisaid is an international initiative that aims to make research data rapidly available to the public. Scientists from all over the world contribute genome sequences of viruses such as H1N1, influenza or SARS-CoV-2 to the database, thus providing a broad overview of mutations and their genetic differences. However, to predict the spread potential of these mutations, a simple count of incidences is not sufficient.
04.03.2021
Mann mit Maske
News
The NoCovid group’s scientists, including HZI researchers Prof Melanie Brinkmann and Prof Michael Meyer-Hermann, have called for extensive testing, faster contact tracing, and a rapid rollout of vaccinations in Germany, arguing that only then will it be possible to open up the economy again. Any reopening in the immediate future threatens to quickly undo the hard-won successes of recent weeks, the group writes in a new paper. This means testing must become a part of everyday life. “If we want the economy to recover, any reopening has to be backed by an effective testing strategy and must not be permitted to lead to a resurgence of infections,” says Clemens Fuest, ifo President and a member of the group.
02.03.2021
Dirk Heinz during his welcoming speech to the Federal Minister of Research, Anja Karliczek
Interview
With the outbreak of the COVID-19 pandemic, the HZI quickly moved into the public spotlight. Scientific Director Prof Dirk Heinz talks about one year of pandemic, the fast establishment of corona research and new challenges
01.03.2021
Antoine-Emmanuel Saliba in the laboratory.
Portrait
“What exactly happens with infections in individual cells? How, where and when does the metabolism within infected cells change? If we manage to gain a better understanding of this, we’ll be able to find starting points for tailored and effective therapies,” says Antoine-Emmanuel Saliba. He has been head of the Single-cell Analysis group at the Würzburg-based Helmholtz Institute for RNA-based Infection Research (HIRI), a branch of the Helmholtz Centre for Infection Research (HZI) headquartered in Braunschweig, Germany, for more than three years.
01.03.2021
Elektronenmikroskopische Aufnahme einer T-Zelle
News
As part of the adaptive immune system, T cells are involved in the defence against pathogens. However, if they recognise healthy, self-structures instead of invading pathogens, autoimmune diseases can result. It is still insufficiently understood which factors are responsible for the dysregulation of the T cells. A new EU-funded programme for young researchers, coordinated by Prof. Jochen Hühn at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, aims to study tissue-resident T cells in more detail. Within the framework of the training network, 15 doctoral students will be trained at academic and non-academic institutions in ten European countries.
01.03.2021

HZI in the media

... fünf Teams durch, darunter PROTON vom Helmholtz-Zentrum für Infektionsforschung. Dieses entwickelt einen neuartigen Wirkstoff gegen ...

22.03.2026
|
Ad Hoc News

Vor allem durch die Coronapandemie sind Forschende des Helmholtz-Zentrums für Infektionsforschung in den vergangenen Jahren bundesweit bekannt geworden. Auf welche Themen die Einrichtung für die Zukunft setzt.

20.03.2026
|
Deutsches Ärzteblatt

... beschäftigt sich daneben unter dem Dach des Helmholtz Institutes für Pharmazeu­tische Forschung Saarland (HIPS) ...

18.03.2026
|
Biermann Medizin

... Ausbau von Produktions- und Vermarktungskapazitäten.

 

Das Helmholtz-Zentrum für Infektionsforschung HZI begrüßt den Erhalt der GMP- ...

18.03.2026
|
Bionity.COM

... der Universität zu Lübeck, des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig, der Medizinischen Hochschule Hannover ...

17.03.2026
|
Biermann Medizin

Vorsorge Das Coronavirus hält die Welt nicht mehr in Atem. Doch was, wenn ein ­anderer gefährlicher Erreger auftaucht? So wappnet sich unser Gesundheitssystem

16.03.2026
|
Apotheken Umschau

... stumpfen ab“, erklärt Marc Brönstrup vom Helmholtz-Zentrum für Infektionsforschung in Braunschweig. Neue Antibiotika sind dringend ...

14.03.2026
|
ARD Mediathek

... der Medizinischen Hochschule Hannover und dem Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig neue Wirkstoffe ...

13.03.2026
|
MTA Dialog

... späten 1990ern hob sie der am Saarbrücker Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) tätige ...

08.03.2026
|
Saarbrücker Zeitung

European institutions, including Germany’s Helmholtz Institute for RNA-based Infection Research, Helmholtz Center for Infection Research,

06.03.2026
|
Clinical Lab Products

Die Zellen kontrollieren die Reaktion des Immunsystems und verhindern Schäden durch Selbstangriffe. Forschende arbeiten daran, sie zur Therapie einzusetzen.

05.03.2026
|
NDR Norddeutscher Rundfunk

Nachwuchsgruppe „Nanoinfektionsbiologie“ am HZI. Diese Lücke soll das Projekt ONEMUC (Respiratorischer Mukus als One Health-Schnittstelle) ...

03.03.2026
|
DeutschesGesundheitsPortal

Register now for the HZI-Newsletter